Arkolith/Insider Trading/NVCT/Form 4/A

Mosseri Marlio Charles

10% OwnerNuvectis Pharma, Inc. (NVCT) · full profile →Form 4/A · filed May 12, 2025
Net Buying
Open-Market Buys
$247K
Open-Market Sells
$0
Net Open-Market Flow
$247K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 9, 2025Buy(P)5K$8.98$48K2.9M
May 9, 2025Buy(P)10K$8.90$87K2.9M
May 9, 2025Buy(P)10K$8.95$88K2.9M
May 8, 2025Buy(P)2K$8.97$22K2.9M
May 8, 2025Buy(P)100$8.71$8712.9M
May 8, 2025Buy(P)100$8.99$8992.9M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4/A filing (accession 0001104659-25-047089) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4/A XML